Knee Joint Injection

From WikiMSK

Revision as of 14:14, 2 April 2021 by Jeremy (talk | contribs) (Created page with "{{procedure |indication= |syringe= |needle= |steroid= |local= |volume= }} ==Anatomy== ==Indications== ==Contraindications== ==Pre-procedural Evaluation== ==Equipment== =...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Knee Joint Injection
Indication


Anatomy

Indications

Contraindications

Pre-procedural Evaluation

Equipment

Technique

Ultrasound Guided

Fluoroscopy Guided

Landmark Guided

Complications

Repetitive intra-articular corticosteroid injections may cause accelerated cartilage loss. McAlindon evaluated triamcinolone vs saline repeated every 12 weeks for 2 years in 141 patients with knee osteoarthritis. The steroid group had greater cartilage loss (-0.21 mm vs -0.10mm), and no significant difference in pain. There was a small increase in HbA1c levels in the steroid group. The steroid group had 5 complications, and the saline group had 3.[1]

Aftercare

Videos

See Also

External Links

References

  1. ↑ McAlindon et al.. Effect of Intra-articular Triamcinolone vs Saline on Knee Cartilage Volume and Pain in Patients With Knee Osteoarthritis: A Randomized Clinical Trial. JAMA 2017. 317:1967-1975. PMID: 28510679. DOI. Full Text.

Literature Review

Library.pngLiterature Review

Retrieved from ‘https://wikimsk.org/w/index.php?title=Knee_Joint_Injection&oldid=6164’